Abstract
The optimal initiation timing of oral anticoagulants (OACs) remains controversial in patients with atrial fibrillation (AF)-related acute ischemic stroke (AIS). The aim of this study is to compare the efficacy and safety of early OACs initiation with that of the delayed initiation for AIS and AF.We searched systematically the following mainstream databases: PubMed, Embase, and Web of Science from the inception to July 2023 for studies that compared the early initiation with the delayed initiation of OACs for AF-related AIS patients. Outcome measures were the incidence of hemorrhagic events, ischemic events, and combined outcomes, as well as all-cause mortality.There were 12 eligible articles included (10 cohort studies and 2 RCT), involving 11421 patients (5690 patients in the early-initiation group and 5731 in the delayed-initiation group). Meta-analysis revealed that patients receiving OACs at the early stage of stroke had a lower incidence of ischemic events (OR: 0.68; 95% CI: 0.55,0.84; p = 0.0003) and combined outcomes (OR=0.74, 95% CI (0.57,0.95), p=0.02). No significant differences were identified in the incidence of hemorrhagic events (p = 0.26) and all-cause mortality ( p = 0.20) between the groups.Early initiation of anticoagulation therapy would be preferable in lowering the incidence of ischemic events and combined outcomes in AIS patients with AF. It is safe compared to the delayed-initiation strategy. However, the conclusion of this study needs to be further validated by more well-designed RCTs.
Similar content being viewed by others
Data Availability
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Group SRiAFW (2007) Independent predictors of stroke in patients with atrial fibrillation: a systematic review. Neurology 69(6):546–554. https://doi.org/10.1212/01.wnl.0000267275.68538.8d
Hart RG, Coull BM, Hart D (1983) Early recurrent embolism associated with nonvalvular atrial fibrillation: a retrospective study. Stroke 14(5):688–693. https://doi.org/10.1161/01.str.14.5.688
Seiffge DJ, Werring DJ, Paciaroni M, Dawson J, Warach S, Milling TJ, Engelter ST et al (2019) Timing of anticoagulation after recent ischaemic stroke in patients with atrial fibrillation. Lancet Neurol 18(1):117–126. https://doi.org/10.1016/s1474-4422(18)30356-9
Mizoguchi T, Tanaka K, Toyoda K, Yoshimura S, Itabashi R, Takagi M, Todo K et al (2020) Early initiation of direct oral Anticoagulants after Onset of Stroke and short- and long-term outcomes of patients with Nonvalvular Atrial Fibrillation. Stroke 51(3):883–891. https://doi.org/10.1161/strokeaha.119.028118
Fischer U, Koga M, Strbian D, Branca M, Abend S, Trelle S, Paciaroni M et al (2023) Early versus later anticoagulation for stroke with Atrial Fibrillation. N Engl J Med 388(26):2411–2421. https://doi.org/10.1056/NEJMoa2303048
Paciaroni M, Agnelli G, Corea F, Ageno W, Alberti A, Lanari A, Caso V et al (2008) Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome: results of a prospective multicenter study. Stroke 39(8):2249–2256. https://doi.org/10.1161/strokeaha.107.510321
Al Bakr AI, AlOmar RS, Nada MAF, Ishaque N, Aljaafari D, Hadhiah K, Al Khmais FA et al (2020) Timing to start anticoagulants after acute ischemic stroke with non-valvular atrial fibrillation. J Neurol Sci 409:116582. https://doi.org/10.1016/j.jns.2019.116582
Matos-Ribeiro J, Castro-Chaves P, Oliveira-Ferreira M, Fonseca L, Pintalhao M (2022) Early anticoagulation in atrial fibrillation-related acute ischaemic stroke: efficacy and safety profile. J Neurol 269(4):2099–2112. https://doi.org/10.1007/s00415-021-10788-z
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https://doi.org/10.1136/bmj.n71
Luo D, Wan X, Liu J, Tong T (2018) Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res 27(6):1785–1805. https://doi.org/10.1177/0962280216669183
Wells G, Shea B, O’Connell D, Peterson j, Welch V, Losos M, Tugwell P (2000) The Newcastle–Ottawa Scale (NOS) for Assessing the Quality of Non-Randomized Studies in Meta-Analysis.
Kim SR, Kim K, Lee SA, Kwon SO, Lee JK, Keum N, Park SM (2019) Effect of Red, processed, and White Meat Consumption on the risk of gastric Cancer: an overall and Dose–Response Meta-Analysis. Nutrients 11(4). https://doi.org/10.3390/nu11040826
Mcpheeters ML, Kripalani S, Peterson NB, Idowu RT, Jerome RN, Potter SA, Andrews JC (2012) Cochrane Risk of Bias Tool. Cochrane Risk of Bias Tool
Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558. https://doi.org/10.1002/sim.1186
De Marchis GM, Seiffge DJ, Schaedelin S, Wilson D, Caso V, Acciarresi M, Tsivgoulis G et al (2022) Early versus late start of direct oral anticoagulants after acute ischaemic stroke linked to atrial fibrillation: an observational study and individual patient data pooled analysis. J Neurol Neurosurg Psychiatry 93(2):119–125. https://doi.org/10.1136/jnnp-2021-327236
Kimura S, Toyoda K, Yoshimura S, Minematsu K, Yasaka M, Paciaroni M, Werring DJ et al (2022) Practical “1-2-3-4-Day” rule for starting direct oral Anticoagulants after ischemic stroke with Atrial Fibrillation: Combined Hospital-Based Cohort Study. Stroke 53(5):1540–1549. https://doi.org/10.1161/strokeaha.121.036695
Kimura T, Tucker A, Nakagaki A, Sugimura T, Fukuda S, Katsuno M, Fujita T et al (2021) Anticoagulation Protocol for secondary Prevention of Acute Ischemic Stroke Associated with Nonvalvular Atrial Fibrillation. J Stroke Cerebrovasc Dis 30(8):105893. https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.105893
Macha K, Volbers B, Bobinger T, Kurka N, Breuer L, Huttner HB, Schwab S et al (2016) Early initiation of anticoagulation with direct oral anticoagulants in patients after transient ischemic attack or ischemic stroke. J Stroke Cerebrovasc Dis 25(9):2317–2321. https://doi.org/10.1016/j.jstrokecerebrovasdis.2016.06.031
Oldgren J, Åsberg S, Hijazi Z, Wester P, Bertilsson M, Norrving B (2022) Early Versus delayed Non-Vitamin K antagonist oral anticoagulant therapy after Acute ischemic stroke in Atrial Fibrillation (TIMING): a Registry-Based Randomized Controlled Noninferiority Study. Circulation 146(14):1056–1066. https://doi.org/10.1161/circulationaha.122.060666
Paciaroni M, Agnelli G, Giustozzi M, Tsivgoulis G, Yaghi S, Grory BM, Furie KL et al (2020) Timing of initiation of oral anticoagulants in patients with acute ischemic stroke and atrial fibrillation comparing posterior and anterior circulation strokes. Eur Stroke J 5(4):374–383. https://doi.org/10.1177/2396987320937116
Wilson D, Ambler G, Banerjee G, Shakeshaft C, Cohen H, Yousry TA, Al-Shahi Salman R et al (2019) Early versus late anticoagulation for ischaemic stroke associated with atrial fibrillation: multicentre cohort study. J Neurol Neurosurg Psychiatry 90(3):320–325. https://doi.org/10.1136/jnnp-2018-318890
Yaghi S, Trivedi T, Henninger N, Giles J, Liu A, Nagy M, Kaushal A et al (2020) Anticoagulation timing in Cardioembolic Stroke and recurrent event risk. Ann Neurol 88(4):807–816. https://doi.org/10.1002/ana.25844
Kamel H, Healey JS (2017) Cardioembolic stroke. Circ Res 120(3):514–526. https://doi.org/10.1161/circresaha.116.308407
Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J et al (2018) 2018 guidelines for the early management of patients with Acute ischemic stroke: a Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke 49(3):e46–e110. https://doi.org/10.1161/str.0000000000000158
Paciaroni M, Agnelli G, Falocci N, Caso V, Becattini C, Marcheselli S, Rueckert C et al (2015) Early recurrence and cerebral bleeding in patients with Acute Ischemic Stroke and Atrial Fibrillation: Effect of Anticoagulation and its timing: the RAF Study. Stroke 46(8):2175–2182. https://doi.org/10.1161/strokeaha.115.008891
Seiffge DJ, Traenka C, Polymeris A, Hert L, Peters N, Lyrer P, Engelter ST et al (2016) Early start of DOAC after ischemic stroke: risk of intracranial hemorrhage and recurrent events. Neurology 87(18):1856–1862. https://doi.org/10.1212/wnl.0000000000003283
Klijn CJ, Paciaroni M, Berge E, Korompoki E, Kõrv J, Lal A, Putaala J et al (2019) Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation: a european Stroke Organisation guideline. Eur Stroke J 4(3):198–223. https://doi.org/10.1177/2396987319841187
Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M et al (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37(38):2893–2962. https://doi.org/10.1093/eurheartj/ehw210
Abdul-Rahim AH, Fulton RL, Frank B, Tatlisumak T, Paciaroni M, Caso V, Diener HC et al (2015) Association of improved outcome in acute ischaemic stroke patients with atrial fibrillation who receive early antithrombotic therapy: analysis from VISTA. Eur J Neurol 22(7):1048–1055. https://doi.org/10.1111/ene.12577
Arihiro S, Todo K, Koga M, Furui E, Kinoshita N, Kimura K, Yamagami H et al (2016) Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: the SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study. Int J Stroke 11(5):565–574. https://doi.org/10.1177/1747493016632239
Canavero I, Cavallini A, Sacchi L, Quaglini S, Arnò N, Perrone P, DeLodovici ML et al (2017) Safely addressing patients with Atrial Fibrillation to Early Anticoagulation after Acute Stroke. J Stroke Cerebrovasc Dis 26(1):7–18. https://doi.org/10.1016/j.jstrokecerebrovasdis.2016.08.022
Gioia LC, Kate M, Sivakumar L, Hussain D, Kalashyan H, Buck B, Bussiere M et al (2016) Early Rivaroxaban Use after Cardioembolic Stroke May not result in Hemorrhagic Transformation: a prospective magnetic resonance imaging study. Stroke 47(7):1917–1919. https://doi.org/10.1161/strokeaha.116.013491
Fischer U, Trelle S, Branca M, Salanti G, Paciaroni M, Ferrari C, Abend S et al (2022) Early versus late initiation of direct oral Anticoagulants in post-ischaemic stroke patients with atrial fibrillatioN (ELAN): protocol for an international, multicentre, randomised-controlled, two-arm, open, assessor-blinded trial. Eur Stroke J 7(4):487–495. https://doi.org/10.1177/23969873221106043
Best JG, Arram L, Ahmed N, Balogun M, Bennett K, Bordea E, Campos MG et al (2022) Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS): protocol for a randomized controlled trial. Int J Stroke 17(5):583–589. https://doi.org/10.1177/17474930211057722
King BT, Lawrence PD, Milling TJ, Warach SJ (2019) Optimal delay time to initiate anticoagulation after ischemic stroke in atrial fibrillation (START): methodology of a pragmatic, response-adaptive, prospective randomized clinical trial. Int J Stroke 14(9):977–982. https://doi.org/10.1177/1747493019870651
Palaiodimou L, Stefanou MI, Katsanos AH, Paciaroni M, Sacco S, De Marchis GM, Shoamanesh A et al (2022) Early Anticoagulation in patients with Acute Ischemic Stroke due to Atrial Fibrillation: a systematic review and Meta-analysis. J Clin Med 11(17). https://doi.org/10.3390/jcm11174981
Acknowledgements
We would like to thank the researchers and study participants for their contributions.
Funding
The authors did not receive support from any organization for the submitted work.
Author information
Authors and Affiliations
Contributions
Conceptualization: Mengjin Jiang; Methodology: Mengjin Jiang, Yaodong Zhang, Congyao Wang; Formal analysis and investigation: Yaodong Zhang, Congyao Wang; Writing - original draft preparation: Mengjin Jiang, Congyao Wang; Writing - review and editing: Mengjin Jiang, Yaodong Zhang. All authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare that they have no competing interest.
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Jiang, M., Wang, C. & Zhang, Y. Comparison of early and delayed anticoagulation therapy after ischemic stroke in patients with atrial fibrillation: a systematic review and meta-analysis. J Thromb Thrombolysis 56, 603–613 (2023). https://doi.org/10.1007/s11239-023-02872-0
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11239-023-02872-0